Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FBIOX vs. RYOIX: which is better?

Bottom line

FBIOX vs RYOIX: the short answer

FBIOX (Biotechnology Portfolio) and RYOIX (Biotechnology Fund) share a meaningful slice of their top holdings — about 53% by weight.

But FBIOX is far broader, holding 215 positions to 74 for RYOIX, so beyond the top names it adds exposure RYOIX doesn't have.

FBIOX is cheaper at 0.62% vs 1.38% — a difference of $76 a year per $10,000 invested.

Over five years, RYOIX returned +4.0% a year vs +3.5% for FBIOX (reporting dates differ).

Updated Nov 19, 2026

FBIOX vs RYOIX side by side

FBIOXRYOIX
TypeMutual fundMutual fund
Fund familyFidelityGuggenheim
CategoryTechnology SectorTechnology Sector
Expense ratio0.62%1.38%
Annual cost per $10k$62$138
10-yr cost on $10k (prospectus)$774$1,709
Max front load——
12b-1 fee0%0%
1-yr return+36.4%+30.7%
5-yr return (annualized)+3.5%+4.0%
10-yr return (annualized)+6.9%+5.9%
Best quarter+33.6%+28.3%
Worst quarter−28.4%−22.5%
Net assets (fund)$5.3B$136.8M
Number of holdings21574
Portfolio turnover45%75%
Returns as ofApr 30, 2026Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFBIOXRYOIXDifference
2025+36.4%+30.7%+5.7%
2024+7.3%−0.7%+8.0%
2023+10.1%+6.1%+4.0%
2022−15.9%−13.1%−2.8%
2021−12.4%+1.8%−14.2%
2020+38.3%+22.1%+16.3%
2019+36.0%+25.0%+10.9%
2018−10.7%−9.0%−1.8%
2017+27.9%+29.7%−1.9%
2016−23.7%−19.5%−4.2%

Source: Fund prospectus bar charts

Holdings overlap

13 of FBIOX's top 25 holdings also appear in RYOIX's top 25.

Shared top holdings
HoldingFBIOXRYOIX
Abbvie Inc9.22%8.17%
Amgen Inc6.53%5.05%
Gilead Sciences Inc4.82%4.49%
Alnylam Pharmaceuticals Inc2.93%2.36%
Insmed Inc2.25%1.79%
Argenx Se2.25%1.48%
Revolution Medicines Inc2.02%2.48%
Jazz Pharmaceuticals Plc1.84%1.42%
Natera Inc1.41%2.12%
Moderna Inc1.28%2.15%
Biogen Inc1.26%2.13%
Roivant Sciences Ltd1.13%1.66%
Bridgebio Pharma Inc0.89%1.38%

Source: SEC Form N-PORT

FBIOX top 10

  1. Krystal Biotech Inc — 10.58%
  2. Abbvie Inc — 9.22%
  3. Amgen Inc — 6.53%
  4. Gilead Sciences Inc — 4.82%
  5. Fidelity Revere Street Trust — 3.35%
  6. Alnylam Pharmaceuticals Inc — 2.93%
  7. Praxis Precision Medicines Inc. — 2.47%
  8. Insmed Inc — 2.25%
  9. Argenx Se — 2.25%
  10. Ascendis Pharma A/s — 2.04%

RYOIX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

FAQ

What is the difference between FBIOX and RYOIX?
FBIOX (Biotechnology Portfolio) and RYOIX (Biotechnology Fund) share a meaningful slice of their top holdings — about 53% by weight. But FBIOX is far broader, holding 215 positions to 74 for RYOIX, so beyond the top names it adds exposure RYOIX doesn't have.
Which is cheaper, FBIOX or RYOIX?
FBIOX has the lower expense ratio (0.62%).
Should I own both FBIOX and RYOIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.